Hemispherx BioPharma (HEB)

[JohnnyD3]

NIH TELEBRIEFING WITH DIRECTOR FRANCIS COLLINS AND INTRAMURAL STUDY TEAM

http://www.meaction.net/2016/03/08/nih-telebriefing-update/

Below is a summary of the Q & A section of the call:

Robert Miller: What homework has been done thus far re Ampligen? Any talk with FDA? Only treatment ever to be in Phase 3 trials for ME/CFS. That opening for this drug potentially could lead to it being our AZT. Opening the door to pharma for much more research, plus give relief to many suffering patients.

Koroshetz: Goal is to try to get a treatment. To start, we are going to challenge our investigators to survey therapeutics that have been tried. Those are more short-term wins should they prove effective. New therapies are longer-term. We have an open door policy for people to come and propose… We have met with many investigators and Hemispherix company people.

They have presented data from previous studies. Serious consideration. There’s a process at NIH for funds to go out, so it’s peer review. We’re working with taxpayer dollars, so the process is very important to uphold. Will be having discussions on clinical trials as they come forward.